Latest news
FDA Approves First Drug That Targets Root Cause of Narcolepsy, Opening New Era for Sleep Disorders - International Business Times, Singapore EditionInternational Business Times, Singapore Edition · Sat, 08 Aug 2026 03:55:01 GMTFDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1 - Managed Healthcare ExecutiveManaged Healthcare Executive · Fri, 07 Aug 2026 20:06:51 GMTFDA approves Takeda’s first-in-class narcolepsy drug - EMJEMJ · Fri, 07 Aug 2026 15:12:52 GMTFDA Approves First Narcolepsy Drug That Targets the Brain Signal Loss Behind the Disorder - Medical DailyMedical Daily · Fri, 07 Aug 2026 10:30:02 GMTThe Difference the New ADHD Drug Named Simtriyo Makes and How It Works in the Brain - inklinkl · Fri, 07 Aug 2026 07:00:00 GMTTakeda Narcolepsy Drug Approval Highlights Beacon Biosignals Partnership - TipRanksTipRanks · Fri, 07 Aug 2026 02:38:24 GMTNew Narcolepsy Drug Signals a Shift From Symptom Management to Disease-Based Treatment - Medical DailyMedical Daily · Fri, 07 Aug 2026 01:30:22 GMTFDA Approves First-in-Class Narcolepsy Drug - MedPage TodayMedPage Today · Thu, 06 Aug 2026 20:46:04 GMT